Drupal.behaviors.print = function(context) {window.print();window.close();}>

Benitec Says European Patent Forthcoming on HCV Inhibition Technology

December 16, 2010

Benitec Says European Patent Forthcoming on HCV Inhibition Technology

The rights to the intellectual property were previously licensed to Tacere Therapeutics, which is developing an shRNA-based HCV therapy with Pfizer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories